Technical Analysis for NK - NantKwest, Inc.

Grade Last Price % Change Price Change
grade C 1.32 -2.94% -0.04
NK closed down 2.94 percent on Thursday, September 19, 2019, on 1.36 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical NK trend table...

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Outside Day Range Expansion 0.00%
Narrow Range Bar Range Contraction -2.94%
NR7 Range Contraction -2.94%
20 DMA Support Bullish 1.54%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.54%
Upper Bollinger Band Walk Strength 1.54%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.22%
Upper Bollinger Band Walk Strength -2.22%
Overbought Stochastic Strength -2.22%

Older signals for NK ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
NantKwest, Inc., a biotechnology company, develops immunotherapeutic agents for various clinical conditions. It is initiating a Phase II clinical trial for its activated natural killer product candidate for the treatment of virally-induced cancers, such as polyomavirus induced Merkel cell carcinoma, human Papillomavirus, induced cervical cancer, and head and neck cancer, as well as infectious diseases comprising Ebola and other viral, fungal, and bacterial infections. The company also holds right to commercialize a range of genetically modified derivatives that kills cancer and virally infected cells. In addition, it focuses on to initiate a Phase I/II clinical trials for target activated natural killer product candidate for acute myeloid leukemia and bulky hematological cancers. The company was formerly known as Conkwest, Inc. and changed its name to NantKwest, Inc. in July 2015. NantKwest, Inc. was founded in 2002 and is headquartered in Cardiff-by-the-Sea, California.
Biotechnology Cancer Infectious Diseases Acute Myeloid Leukemia Infectious Causes Of Cancer Bacterial Infections Head And Neck Cancer Virus Human Papillomavirus Infection Carcinogenesis Cervical Cancer Ebola Merkel Cell Carcinoma Papillomavirus
Is NK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.23
52 Week Low 0.93
Average Volume 158,266
200-Day Moving Average 1.2267
50-Day Moving Average 1.2698
20-Day Moving Average 1.288
10-Day Moving Average 1.327
Average True Range 0.0807
ADX 23.47
+DI 20.4545
-DI 12.3983
Chandelier Exit (Long, 3 ATRs ) 1.1579
Chandelier Exit (Short, 3 ATRs ) 1.4021
Upper Bollinger Band 1.4074
Lower Bollinger Band 1.1686
Percent B (%b) 0.63
BandWidth 18.540373
MACD Line 0.0238
MACD Signal Line 0.0198
MACD Histogram 0.004
Fundamentals Value
Market Cap 104.86 Million
Num Shares 79.4 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -1.02
Price-to-Sales 7227.62
Price-to-Book 1.46
PEG Ratio 2.18
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.44
Resistance 3 (R3) 1.45 1.43 1.42
Resistance 2 (R2) 1.43 1.40 1.42 1.41
Resistance 1 (R1) 1.37 1.38 1.36 1.36 1.41
Pivot Point 1.35 1.35 1.34 1.34 1.35
Support 1 (S1) 1.29 1.32 1.28 1.28 1.23
Support 2 (S2) 1.27 1.30 1.26 1.23
Support 3 (S3) 1.21 1.27 1.22
Support 4 (S4) 1.20